Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Continuous low-dose acetylsalicylic acid (aspirin; ASA) is a mainstay of cardiovascular (CV) risk management. It is well established, however, that troublesome upper gastrointestinal (GI) symptoms are commonly experienced among low-dose ASA users.
Originalsprog | Engelsk |
---|---|
Tidsskrift | American Journal of Cardiovascular Drugs |
Vol/bind | 13 |
Udgave nummer | 1 |
Sider (fra-til) | 27-35 |
Antal sider | 9 |
ISSN | 1175-3277 |
DOI | |
Status | Udgivet - feb. 2013 |
ID: 47892408